medRxiv PreprintsInternational15 November 2026
Estimating the Economic Burden of Typhoid Fever in Ibadan, Nigeria
This is an official announcement record
Firsthand records what medRxiv Preprints announced and links to the original. The wording below is theirs, not ours.
Background: Evidence on the economic burden of typhoid fever remains limited in sub-Saharan Africa. This study estimated the costs associated with typhoid fever and related invasive Salmonella infections in Ibadan, Nigeria. Methods: A field-based cost-of-illness study was conducted at six healthcare facilities between 2022 and 2025. Patients with Salmonella enterica serovar Typhi (S. Typhi), Salmonella enterica serovar Paratyphi (S. Paratyphi), invasive non-typhoidal Salmonella (iNTS), or typhoid gastrointestinal perforation (special cases) were enrolled, with malaria patients serving as contr
Read the official announcement
Opens www.medrxiv.org
More from medRxiv Preprints
- Unmet needs of Polish patients with cystic fibrosis seen through the lens of crowdfunding20 November 2026
- Motherly Plus: Study Protocol of a Randomized Controlled Trial Evaluating a Smartphone-Assisted Single-Session Psychotherapy Intervention for Postpartum Depression20 November 2026
- Targeting memory consolidation in major depression via pharmacological slow-wave sleep promotion20 November 2026
- Epidemiology of Cardiac Structure and Function Among African Caribbeans in Tobago: A Population-based Cohort Study20 November 2026
- Depressive Symptom Trajectories and Incident Cognitive Impairment by Outcome Ascertainment20 November 2026
This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program: especially if you are pregnant, nursing, taking medication, or managing a health condition.